Anti-infection
-
BA1942 Darunavir-d9Summary: Darunavir-d9 (TMC114-d9) is the deuterium substitute for Darunavir. - BA1943 NifevirocSummary: Nifeviroc is an antagonist with oral activity.
- BA1948 2-Deoxy-2-fluoroarabinoadenosineSummary: 2'-Deoxy-2'-fluoroarabinoadenosine is a nucleoside analog.
- BA1951 DPC-681Summary: DPC-681 is a potent and selective HIVprotease inhibitor.
- BA1953 PirmitegravirSummary: Pirmitegravir is a potent, first-in-class inhibitor targeting the LEDGF/p75 binding site.
- BA1958 PeldesineSummary: Peldesine (BCX34) is a potent, competitive, reversible and orally active purine nucleoside phosphorylase inhibitor.
- BA1959 AzddMeCSummary: AzddMeC (CS-92) is an antiviral nucleoside analog and a potent, selective, orally active inhibitor of reverse transcriptase and replication.
- BA1966 BDM-2Summary: BDM-2 is an IN-LEDGF-altering inhibitor (INLAI) of integrase (=47nM) and has potent antiretroviral (ARV) activity.
- BA1976 HIV-IN-6Summary: HIV-IN-6 is an HIV-I viral replication inhibitor.
- BA1977 CDK9-IN-30Summary: CDK9-IN-30 is an inhibitor.